Promising trials of malaria vaccine in East Africa lead to calls for Phase 3 development
Potential for vaccines to be integrated into existing infant vaccination programmes in Sub Saharan Africa. Experts are recommending that a malaria vaccine progress to Phase 3 trials following the successful trial of the RTS, S/AS01E malaria vaccine among 5-17 month old children in Korogwe, Tanzania and coastal Kenya. Full malaria vaccine story